Skip to main content

Castle Biosciences Inc

CSTL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001447362

In the last 90 days, Castle Biosciences Inc insiders filed 0 open-market purchases and 21 sales; 176 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Castle Biosciences Inc changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of CSTL: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1863176−7
Shares27.6M18.1K27.4M−182.5K (−0.7%)
Value$677.8M$443.1K$653.8M−$23.5M (−3.5%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (23)

Institutions that held Castle Biosciences Inc at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CSTL in Q2 2026
InstitutionSharesValue% of portfolio
Jefferies Financial Group Inc.647,391$15.4M0.14%
Point72 Asset Management, L.P.357,317$8.52M0.01%
Kennedy Capital Management, Inc.348,371$8.31M0.15%
First Trust Advisors LP145,064$3.46M0.00%
Norges Bank60,100$1.43M0.00%
Toroso Investments, LLC22,186$529.1K0.00%
Counterpoint Mutual Funds LLC16,510$393.8K0.04%
Diversify Advisory Services, LLC15,932$389.4K0.01%
Jupiter Topco LLC15,037$358.2K0.00%
Quadrature Capital Ltd10,175$242.7K0.00%
Allstate Corp9,642$230.0K0.00%
EntryPoint Capital, LLC8,942$213.3K0.05%
Intech Investment Management LLC8,580$204.6K0.00%
Global Retirement Partners, LLC1,100$26.2K0.00%
GWM Advisors LLC842$20.1K0.00%
Nykredit A/S597$14.2K0.00%
National Bank of Canada191$4.55K0.00%
Optiver Holding B.V.174$4.15K0.00%
Silver Grove Financial Group, Inc.156$3.72K0.00%
Clearstead Advisors, LLC48$1.15K0.00%
Caitong International Asset Management Co., Ltd6$1430.00%
Fortitude Family Office, LLC1$240.00%
Freestone Grove Partners LP1$240.00%

Sold out (30)

Institutions that held Castle Biosciences Inc at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (3)

Institutions that held Castle Biosciences Inc at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CSTL in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Janus Henderson Group PLC15,037$369.1K
CWM, LLC3,010$73.9K
Sunbelt Securities, Inc.3$74